Skip to content
PubMed This is a summary of 55 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 55 referenced papers

Top Authors

Marina Vivarelli
Bambino Gesù Children's Hospital
Vivekanand Jha
Manipal Academy of Higher Education
David R.W. Jayne
University of Cambridge
Jai Radhakrishnan
Columbia University Irving Medical Center
Andrew S. Bomback
Columbia University Irving Medical Center
Jürgen Floege
Universitätsklinikum Aachen
Keisha L. Gibson
University of North Carolina at Chapel Hill
Suja Somanadhan
University College Dublin
Thilo Kroll
University College Dublin
Hae Yoon Grace Choung
University of Rochester Medicine

Top Institutions

Ranked by publications Top 10 institutions
04
09

Medical University of South Carolina

Charleston, United States

12 papers
10

Manipal Academy of Higher Education

Manipal, India

11 papers
Contributors Vivekanand Jha

References

References (55)
  1. 1

    Antinuclear Antibody-Negative Lupus Nephritis with Full House Nephropathy: A Case Report and Review of the Literature.

    Simmons SC, Smith ML, Chang-Miller A, Keddis MT

    American journal of nephrology 2015; (42(6)):451-9 doi:10.1159/000443747.

    PMID: 26812129
  2. 2

    Diagnosis and Management of Nephrotic Syndrome in Adults.

    Kodner C

    American family physician 2016; (93(6)):479-85.

    PMID: 26977832
  3. 3

    Sodium intake, RAAS-blockade and progressive renal disease.

    de Borst MH, Navis G

    Pharmacological research 2016; (107()):344-351 doi:10.1016/j.phrs.2016.03.037.

    PMID: 27041482
  4. 4

    Outcome of childhood-onset full-house nephropathy.

    Ruggiero B, Vivarelli M, Gianviti A, et al.

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2017; (32(7)):1194-1204 doi:10.1093/ndt/gfw230.

    PMID: 27270291
  5. 5

    Nephrotic syndrome-induced thromboembolism in adults.

    Al-Azzawi HF, Obi OC, Safi J, Song M

    International journal of critical illness and injury science 2016; (6(2)):85-8 doi:10.4103/2229-5151.183019.

    PMID: 27308257
  6. 6

    Idiopathic non-lupus full-house nephropathy is associated with poor renal outcome.

    Rijnink EC, Teng YK, Kraaij T, et al.

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2017; (32(4)):654-662 doi:10.1093/ndt/gfx020.

    PMID: 28340077
  7. 7

    Urinary Tract Infection in Children With Nephrotic Syndrome.

    Narain U, Gupta A

    The Pediatric infectious disease journal 2018; (37(2)):144-146 doi:10.1097/INF.0000000000001747.

    PMID: 28827494
  8. 8

    Tubuloreticular Inclusions in the Absence of Systemic Lupus Erythematosus and HIV Infection: A Report of Three Pediatric Cases.

    Elmaghrabi A, Brown E, Khin E, et al.

    Case reports in nephrology and dialysis 2017; (7(2)):91-101 doi:10.1159/000477661.

    PMID: 28868299
  9. 9

    Proliferative lupus nephritis in the absence of overt systemic lupus erythematosus: A historical study of 12 adult patients.

    Touzot M, Terrier CS, Faguer S, et al.

    Medicine 2017; (96(48)):e9017 doi:10.1097/MD.0000000000009017.

    PMID: 29310419
  10. 10

    [ACE Inhibitors and ARB in Chronic Kidney Disease: What Has to Be Considered].

    Zeier M

    Deutsche medizinische Wochenschrift (1946) 2018; (143(12)):880-885 doi:10.1055/a-0549-9662.

    PMID: 29898489
  11. 11

    Drug-induced systemic lupus: revisiting the ever-changing spectrum of the disease using the WHO pharmacovigilance database.

    Arnaud L, Mertz P, Gavand PE, et al.

    Annals of the rheumatic diseases 2019; (78(4)):504-508 doi:10.1136/annrheumdis-2018-214598.

    PMID: 30793701
  12. 12

    2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus.

    Aringer M, Costenbader K, Daikh D, et al.

    Arthritis & rheumatology (Hoboken, N.J.) 2019; (71(9)):1400-1412 doi:10.1002/art.40930.

    PMID: 31385462
  13. 13

    A case of membranous nephropathy diagnosed with lupus nephritis 11 years after onset.

    Yamada T, Itagaki F, Aratani S, et al.

    CEN case reports 2019; (8(4)):301-307 doi:10.1007/s13730-019-00412-5.

    PMID: 31399881
  14. 14

    Stand-alone renal SLICC criterion with full house glomerular deposits: is it enough for childhood lupus nephritis?

    Almutairi A, Aljammz H, Al-Hussain T, Al-Mayouf SM

    Clinical rheumatology 2020; (39(2)):401-405 doi:10.1007/s10067-019-04789-7.

    PMID: 31637610
  15. 15

    Steroid-Associated Side Effects in Patients With Primary Proteinuric Kidney Disease.

    Oh GJ, Waldo A, Paez-Cruz F, et al.

    Kidney international reports 2019; (4(11)):1608-1616 doi:10.1016/j.ekir.2019.08.019.

    PMID: 31891002
  16. 16

    Infections in Children With Nephrotic Syndrome: Twenty Years of Experience.

    Lebel A, Kropach N, Ashkenazi-Hoffnung L, et al.

    Clinical pediatrics 2020; (59(7)):692-698 doi:10.1177/0009922820908583.

    PMID: 32116004
  17. 17

    Study on the correlation between anti-ribosomal P protein antibody and systemic lupus erythematosus.

    Wang Y, Luo P, Guo T, et al.

    Medicine 2020; (99(20)):e20192 doi:10.1097/MD.0000000000020192.

    PMID: 32443340
  18. 18

    Patient and clinician opinions of patient reported outcome measures (PROMs) in the management of patients with rare diseases: a qualitative study.

    Aiyegbusi OL, Isa F, Kyte D, et al.

    Health and quality of life outcomes 2020; (18(1)):177 doi:10.1186/s12955-020-01438-5.

    PMID: 32522194
  19. 19

    Non-lupus full house nephropathy in pediatrics: Case reports

    Guerrero GA, Guerrero LF, González T

    Biomedica : revista del Instituto Nacional de Salud 2020; (40(2)):220-227 doi:10.7705/biomedica.4863.

    PMID: 32673451
  20. 20

    Clinicopathological Pattern of Non-lupus Full House Nephropathy.

    Wani AS, Zahir Z, Gupta A, Agrawal V

    Indian journal of nephrology 2020; (30(5)):301-306 doi:10.4103/ijn.IJN_91_18.

    PMID: 33707816
  21. 21

    Lupus-Like Glomerulonephritis Associated With Regorafenib, a Multikinase Inhibitor.

    Strasma A, Coke H, Mamlouk O, et al.

    Kidney medicine 2021; (3(2)):294-298 doi:10.1016/j.xkme.2020.11.011.

    PMID: 33851126
  22. 22

    Anti-neutrophil cytoplasmic antibody associated glomerulonephritis complicating treatment with hydralazine.

    Santoriello D, Bomback AS, Kudose S, et al.

    Kidney international 2021; (100(2)):440-446 doi:10.1016/j.kint.2021.03.029.

    PMID: 33857570
  23. 23

    Renal outcomes of idiopathic and atypical membranous nephropathy in adult Chinese patients: a single center retrospective cohort study.

    Jiang Z, Cai M, Dong B, et al.

    BMC nephrology 2021; (22(1)):148 doi:10.1186/s12882-021-02348-4.

    PMID: 33888083
  24. 24

    Lupus-like membranous nephropathy. Is it lupus? Report of 5 cases in a reference hospital in Mexico.

    Ramírez-Gómez LM, Ruiz-Leija I, Martínez-Galla D, et al.

    Lupus 2021; (30(8)):1347-1357 doi:10.1177/09612033211013584.

    PMID: 33977794
  25. 25

    Being the Pillar for Children with Rare Diseases-A Systematic Review on Parental Quality of Life.

    Boettcher J, Boettcher M, Wiegand-Grefe S, Zapf H

    International journal of environmental research and public health 2021; (18(9)) doi:10.3390/ijerph18094993.

    PMID: 34066738
  26. 26

    Membranous nephropathy.

    Ronco P, Beck L, Debiec H, et al.

    Nature reviews. Disease primers 2021; (7(1)):69 doi:10.1038/s41572-021-00303-z.

    PMID: 34593809
  27. 27

    Risk of Arterial Thromboembolism, Venous Thromboembolism, and Bleeding in Patients with Nephrotic Syndrome: A Population-Based Cohort Study.

    Vestergaard SV, Birn H, Darvalics B, et al.

    The American journal of medicine 2022; (135(5)):615-625.e9 doi:10.1016/j.amjmed.2021.11.018.

    PMID: 34979093
  28. 28

    An Interesting Case of Nonlupus Full-House Nephropathy.

    Sathi S, Sharma A, Garg AK, et al.

    Case reports in nephrology 2021; (2021()):9043003 doi:10.1155/2021/9043003.

    PMID: 34992890
  29. 29

    Clinicopathological Study of Nonlupus "Full-House" Nephropathy.

    Sadineni R, Das U

    Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 2021; (32(3)):680-690 doi:10.4103/1319-2442.336762.

    PMID: 35102909
  30. 30

    Perspective on COVID-19 vaccination in patients with immune-mediated kidney diseases: consensus statements from the ERA-IWG and EUVAS.

    Stevens KI, Frangou E, Shin JIL, et al.

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2022; (37(8)):1400-1410 doi:10.1093/ndt/gfac052.

    PMID: 35244174
  31. 31

    Rapidly progressive glomerulonephritis in children.

    Moorani KN, Aziz M, Amanullah F

    Pakistan journal of medical sciences 2022; (38(2)):417-425 doi:10.12669/pjms.38.ICON-2022.5774.

    PMID: 35310798
  32. 32

    The spectrum of renal diseases with lupus-like features: a single-center study.

    Ahmed M, Love T, Moore C, et al.

    Renal failure 2022; (44(1)):581-593 doi:10.1080/0886022X.2022.2057862.

    PMID: 35357272
  33. 33

    Bartonella endocarditis and diffuse crescentic proliferative glomerulonephritis with a full-house pattern of immune complex deposition.

    Guo S, Pottanat ND, Herrmann JL, Schamberger MS

    BMC nephrology 2022; (23(1)):181 doi:10.1186/s12882-022-02811-w.

    PMID: 35549887
  34. 34

    Psychosocial Considerations for the Child with Rare Disease: A Review with Recommendations and Calls to Action.

    Belzer LT, Wright SM, Goodwin EJ, et al.

    Children (Basel, Switzerland) 2022; (9(7)) doi:10.3390/children9070933.

    PMID: 35883917
  35. 35

    Immunosuppression Exposure and Risk of Infection-Related Acute Care Events in Patients With Glomerular Disease: An Observational Cohort Study.

    Glenn DA, Zee J, Mansfield S, et al.

    Kidney medicine 2022; (4(11)):100553 doi:10.1016/j.xkme.2022.100553.

    PMID: 36339665
  36. 36

    Glomerulonephritides associated with infections.

    Havrda M

    Vnitrni lekarstvi 2022; (68(7)):432-437 doi:10.36290/vnl.2022.091.

    PMID: 36402567
  37. 37

    Idiopathic Nonlupus Full-House Nephropathy: Clinicopathological Presentation and Comparison with Lupus Full-House Nephropathy.

    Mahanta P, Alam S, Parry MA, et al.

    Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 2022; (33(1)):37-45 doi:10.4103/1319-2442.367824.

    PMID: 36647977
  38. 38

    The Clinicopathologic Spectrum of Membranous Nephropathy with Lupus-Like Features.

    Choung HYG, Moore C, Le TH, et al.

    Nephron 2023; (147(7)):424-433 doi:10.1159/000529437.

    PMID: 36746127
  39. 39

    A Rare Case of Antinuclear Antibody (ANA)-Negative Lupus Nephritis.

    Bakshi N, Munir T, Guma M, Chenitz KB

    Cureus 2023; (15(7)):e41480 doi:10.7759/cureus.41480.

    PMID: 37426404
  40. 40

    Nephrotic syndrome: pathophysiology and consequences.

    Ponticelli C, Moroni G

    Journal of nephrology 2023; (36(8)):2179-2190 doi:10.1007/s40620-023-01697-7.

    PMID: 37466816
  41. 41

    A case of non-lupus full-house nephropathy diagnosed by kidney biopsy but observed IgA nephropathy on second biopsy.

    Iwafuchi Y, Morioka T, Oyama Y, Narita I

    CEN case reports 2024; (13(5)):373-380 doi:10.1007/s13730-024-00860-8.

    PMID: 38421587
  42. 42

    Interventions to support young adults and families with the healthcare transition between paediatric and adult nephrology health services: A systematic scoping review.

    Kinch M, Kroll T, Buckle N, Somanadhan S

    Journal of pediatric nursing 2024; (78()):e346-e363 doi:10.1016/j.pedn.2024.07.026.

    PMID: 39153916
  43. 43

    Proteinuria and Progression of Renal Damage: The Main Pathogenetic Mechanisms and Pharmacological Approach.

    Longhitano E, Calabrese V, Casuscelli C, et al.

    Medicina (Kaunas, Lithuania) 2024; (60(11)) doi:10.3390/medicina60111821.

    PMID: 39597006
  44. 44

    Systematic Scoping Review of Socioeconomic Burden and Associated Psychosocial Impact in Patients With Rare Kidney Diseases and Their Caregivers.

    Palagyi A, Sengupta A, Moorthy M, et al.

    Kidney international reports 2025; (10(3)):838-854 doi:10.1016/j.ekir.2024.12.005.

    PMID: 40225371
  45. 45

    Executive summary of the KDIGO 2025 Clinical Practice Guideline for the Management of Nephrotic Syndrome in Children.

    Floege J, Gibson KL, Vivarelli M, et al.

    Kidney international 2025; (107(5)):806-808 doi:10.1016/j.kint.2024.11.006.

    PMID: 40254362
  46. 46

    Pneumonia-Masked Pulmonary Embolism in Nephrotic Syndrome: Diagnostic Value of V/Q Scintigraphy: A Case Report.

    Saiki R, Katayama K, Murata T, Dohi K

    Reports (MDPI) 2025; (8(2)) doi:10.3390/reports8020042.

    PMID: 40710833
  47. 47

    Lupus or not? Idiopathic full house glomerulonephritis: a rare nephropathy with unexpectedly severe outcome.

    Sciascia S, Cozzi M, Fadaeibahreini A, et al.

    Clinical and experimental rheumatology 2025; (43(11)):1848-1854 doi:10.55563/clinexprheumatol/fl31td.

    PMID: 41004327
  48. 48

    Rapid renal salvage in acute renal vein thrombosis secondary to membranous nephropathy using large-bore mechanical thrombectomy.

    Singh SD, Gan CC, Lee L, et al.

    Thrombosis journal 2026; (24(1)).

    PMID: 41896885
  49. 49

    Pediatric Non-Lupus Full House Nephropathy: Case Report and Review of Literature.

    Anjum MF, Sah S, Khanal I, et al.

    Clinical case reports 2026; (14(3)):e72232 doi:10.1002/ccr3.72232.

    PMID: 42016628
  50. 50

    Thromboembolic complications unmasking membranous nephropathy: diagnostic and therapeutic challenges.

    Mann J, Khairati R, Huma ZE, Nafisa S

    BMJ case reports 2026; (19(4)) doi:10.1136/bcr-2025-270721.

    PMID: 42031390
  51. 51

    First Description of Nonlupus Full-House Nephropathy in Systemic Juvenile Idiopathic Arthritis Responsive to High-Dose Tocilizumab.

    Jacobs L, Badot V, Nagant C, et al.

    Kidney medicine 2026; (8(7)):101380 doi:10.1016/j.xkme.2026.101380.

    PMID: 42232821
  52. 52

    The river meeting the sea: A qualitative exploration of the healthcare transition experiences of adolescents and young adults living with rare renal disorders and their parents.

    Kinch M, Kroll T, Somanadhan S

    PloS one 2026; (21(6)):e0348445 doi:10.1371/journal.pone.0348445.

    PMID: 42234728
  53. 53

    Clinical and histopathological predictors of systemic lupus erythematosus in a South American cohort of patients with full-house glomerulonephritis.

    Tanten Zabaleta R, Espejo E, Scaglioni V, et al.

    Lupus 2026; (35(10)):1058-1065 doi:10.1177/09612033261463575.

    PMID: 42334098
  54. 54

    Cascade of opportunistic infections in focal segmental glomerulosclerosis under dual immunosuppressive therapy: a case report.

    Wu CH, Lee JJ, Hwang DY, et al.

    Frontiers in immunology 2026; (17()):1838232 doi:10.3389/fimmu.2026.1838232.

    PMID: 42591115
  55. 55

    Clinicopathologic Spectrum and Treatment Response of Syphilis-Associated Kidney Disease: A Systematic Review.

    Long X, Lin W, Liu D

    American journal of kidney diseases : the official journal of the National Kidney Foundation 2026; doi:10.1053/j.ajkd.2026.06.037.

    PMID: 42966598